High Roller's third-quarter 2026 earnings reflect declining casino revenues and widening losses, while its prediction markets platform offers growth potential.
CoreWeave trades at a steep discount despite strong AI demand and a $132.5B backlog, but high debt costs, massive capex and customer concentration cloud its appeal.
CoreWeave's $132.5B backlog signals massive AI demand, but rising interest costs and infrastructure execution challenges could delay its profitability payoff.
CoreWeave shares surged 14.5% in a week despite steep longer-term losses. Can soaring AI demand and a $132.5B backlog offset heavy debt costs and sustain the rebound?
Star Bulk raises its quarterly dividend to $1 per share as stronger freight rates boost cash flow, while higher Q4 bookings signal continued earnings momentum.
INTU cuts its fiscal 2027 revenue outlook as Credit Karma faces headwinds, while strong Q1 earnings, AI expansion and the Mailchimp sale shape its strategy.
Keysight targets 20% revenue growth in fiscal 2027 as surging AI testing demand strains supply, drives record backlog and prompts manufacturing expansion.
Walmart raises its fiscal 2027 sales and profit outlook as e-commerce surges, online margins improve and membership gains fuel optimism ahead of the holidays.
RCAT withdraws its 2026 sales target as defense funding delays and missed contracts weigh on results, while Blue Ops and Steyr offer new opportunities.
The average of price targets set by Wall Street analysts indicates a potential upside of 128.7% in GH Research (GHRS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The average of price targets set by Wall Street analysts indicates a potential upside of 29.7% in BrightSpring Health Services, Inc. (BTSG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The consensus price target hints at a 25.8% upside potential for Callaway (CALY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
The average of price targets set by Wall Street analysts indicates a potential upside of 28.4% in Consensus Cloud Solutions (CCSI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The consensus price target hints at a 27.4% upside potential for Encore Capital Group (ECPG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
The average of price targets set by Wall Street analysts indicates a potential upside of 42.3% in Amphenol (APH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The consensus price target hints at a 70.1% upside potential for Coherent (COHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
The consensus price target hints at a 39.4% upside potential for RB Global (RBA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.